Long-term consequences of hematopoietic stem cell transplantation: current state of the science.
作者信息
Baker K Scott, Armenian Saro, Bhatia Smita
机构信息
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
出版信息
Biol Blood Marrow Transplant. 2010 Jan;16(1 Suppl):S90-6. doi: 10.1016/j.bbmt.2009.09.017. Epub 2009 Sep 24.
Abstract
摘要
相似文献
1
Long-term consequences of hematopoietic stem cell transplantation: current state of the science.造血干细胞移植的长期后果：科学现状
Biol Blood Marrow Transplant. 2010 Jan;16(1 Suppl):S90-6. doi: 10.1016/j.bbmt.2009.09.017. Epub 2009 Sep 24.
2
Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation.造血细胞移植后幸存者的代谢综合征与心血管风险。
Bone Marrow Transplant. 2012 May;47(5):619-25. doi: 10.1038/bmt.2011.118. Epub 2011 Jun 6.
3
Risk factors of cardiovascular disease after hematopoietic cell transplantation.造血细胞移植后心血管疾病的危险因素。
Clin Adv Hematol Oncol. 2013 Feb;11(2):104-5.
4
Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.异基因造血干细胞移植后的晚期心血管事件：欧洲血液与骨髓移植组晚期效应工作组的一项回顾性多中心研究
Haematologica. 2008 Aug;93(8):1203-10. doi: 10.3324/haematol.12949. Epub 2008 Jun 12.
5
Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT.造血细胞移植后的代谢综合征与心血管疾病：CIBMTR和EBMT的筛查及预防实践建议
Biol Blood Marrow Transplant. 2016 Aug;22(8):1493-1503. doi: 10.1016/j.bbmt.2016.05.007. Epub 2016 May 14.
6
Metabolic Syndrome and Cardiovascular Risk Factors after Hematopoietic Cell Transplantation in Severe Mucopolysaccharidosis Type I (Hurler Syndrome).代谢综合征与造血干细胞移植治疗重型黏多糖贮积症Ⅰ型（Hurler 综合征）后的心血管危险因素。
Biol Blood Marrow Transplant. 2018 Jun;24(6):1289-1293. doi: 10.1016/j.bbmt.2018.01.028. Epub 2018 Feb 1.
7
Metabolic Syndrome in Long-Term Survivors of Hematopoietic Stem-Cell Transplantation.造血干细胞移植长期存活者的代谢综合征
Clin Lymphoma Myeloma Leuk. 2017 Jun;17(6):340-346. doi: 10.1016/j.clml.2017.05.004. Epub 2017 May 10.
8
Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT.造血细胞移植后的代谢综合征与心血管疾病：CIBMTR和EBMT的筛查及预防实践建议
Bone Marrow Transplant. 2017 Feb;52(2):173-182. doi: 10.1038/bmt.2016.203. Epub 2016 Aug 22.
9
Cardiovascular and Metabolic Consequences of Liver Transplantation: A Review.肝移植的心血管和代谢后果：综述。
Medicina (Kaunas). 2019 Aug 15;55(8):489. doi: 10.3390/medicina55080489.
10
Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation.异基因造血干细胞移植后的早发性心血管疾病。
Blood. 2007 Nov 1;110(9):3463-71. doi: 10.1182/blood-2006-10-054080. Epub 2007 Jul 30.
引用本文的文献
1
Health care utilization by long-term survivors of blood or marrow transplantation-A Bone Marrow Transplant Survivor Study report.血液或骨髓移植长期幸存者的医疗保健利用情况——一份骨髓移植幸存者研究报告。
Cancer. 2024 Mar 1;130(5):803-815. doi: 10.1002/cncr.35076. Epub 2023 Oct 25.
2
Late Effects After Haematopoietic Stem Cell Transplantation in ALL, Long-Term Follow-Up and Transition: A Step Into Adult Life.急性淋巴细胞白血病造血干细胞移植后的晚期效应、长期随访与过渡：迈向成人生活的一步
Front Pediatr. 2021 Nov 24;9:773895. doi: 10.3389/fped.2021.773895. eCollection 2021.
3
Cancer-related accelerated ageing and biobehavioural modifiers: a framework for research and clinical care.癌症相关的加速衰老与生物行为修饰因子：研究与临床照护的架构。
Nat Rev Clin Oncol. 2022 Mar;19(3):173-187. doi: 10.1038/s41571-021-00580-3. Epub 2021 Dec 6.
4
Cardiovascular Issues in Hematopoietic Stem Cell Transplantation (HSCT).造血干细胞移植（HSCT）中的心血管问题。
Curr Treat Options Oncol. 2021 Apr 30;22(6):51. doi: 10.1007/s11864-021-00850-3.
5
Assessing Cancer Treatment Information Using Medicare and Hospital Discharge Data among Women with Non-Hodgkin Lymphoma in a Los Angeles County Case-Control Study.使用洛杉矶县病例对照研究中的医疗保险和住院数据评估非霍奇金淋巴瘤女性的癌症治疗信息。
Cancer Epidemiol Biomarkers Prev. 2020 May;29(5):936-941. doi: 10.1158/1055-9965.EPI-19-1504. Epub 2020 Feb 17.
6
Indirect costs associated with premature mortality among those with veno-occlusive disease/sinusoidal obstruction syndrome with multiorgan dysfunction post-hematopoietic stem-cell-transplant.造血干细胞移植后患有静脉闭塞性疾病/窦性阻塞综合征并伴有多器官功能障碍者过早死亡的间接成本。
Clinicoecon Outcomes Res. 2018 Dec 17;11:13-22. doi: 10.2147/CEOR.S184883. eCollection 2019.
7
"Improving to where?": treatment-related health risks and perceptions of the future among adolescents and young adults after hematopoietic cell transplantation.“改善到什么程度？”：造血细胞移植后青少年和年轻成人的与治疗相关的健康风险和对未来的看法。
Support Care Cancer. 2019 Feb;27(2):623-630. doi: 10.1007/s00520-018-4350-7. Epub 2018 Jul 24.
8
Engagement with INSPIRE, an Online Program for Hematopoietic Cell Transplantation Survivors.参与 INSPIRE，一个针对造血细胞移植幸存者的在线项目。
Biol Blood Marrow Transplant. 2018 Aug;24(8):1692-1698. doi: 10.1016/j.bbmt.2018.05.004. Epub 2018 May 9.
9
Coming of Age With Cancer: Physical, Social, and Financial Barriers to Independence Among Emerging Adult Survivors.与癌症一同成长：成年初期幸存者实现独立所面临的身体、社会和经济障碍。
Oncol Nurs Forum. 2018 Mar 1;45(2):148-158. doi: 10.1188/18.ONF.148-158.
10
"From Snail Mode to Rocket Ship Mode": Adolescents and Young Adults' Experiences of Returning to Work and School After Hematopoietic Cell Transplantation.“从蜗牛模式到火箭飞船模式”：造血干细胞移植后青少年和青年重返工作和学校的经历
J Adolesc Young Adult Oncol. 2017 Dec;6(4):551-559. doi: 10.1089/jayao.2017.0025. Epub 2017 Jun 8.
本文引用的文献
1
Solid cancers after allogeneic hematopoietic cell transplantation.异基因造血细胞移植后的实体癌。
Blood. 2009 Jan 29;113(5):1175-83. doi: 10.1182/blood-2008-05-158782. Epub 2008 Oct 29.
2
Late congestive heart failure after hematopoietic cell transplantation.造血细胞移植后晚期充血性心力衰竭
J Clin Oncol. 2008 Dec 1;26(34):5537-43. doi: 10.1200/JCO.2008.17.7428. Epub 2008 Sep 22.
3
Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation.造血细胞移植长期存活者中慢性肾脏病延迟发生的发生率及预测因素
Cancer. 2008 Oct 1;113(7):1580-7. doi: 10.1002/cncr.23773.
4
Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer.儿童癌症后发生蒽环类药物相关充血性心力衰竭患者的羰基还原酶3基因（CBR3）和NAD（P）H：醌氧化还原酶1基因（NQO1）中的基因多态性。
Cancer. 2008 Jun 15;112(12):2789-95. doi: 10.1002/cncr.23534.
5
Inhibition of polymorphic human carbonyl reductase 1 (CBR1) by the cardioprotectant flavonoid 7-monohydroxyethyl rutoside (monoHER).心脏保护类黄酮7-单羟基乙基芦丁（monoHER）对多态性人羰基还原酶1（CBR1）的抑制作用
Pharm Res. 2008 Jul;25(7):1730-4. doi: 10.1007/s11095-008-9592-5. Epub 2008 May 1.
6
Long-term cardiac and pulmonary complications of cancer therapy.癌症治疗的长期心脏和肺部并发症。
Hematol Oncol Clin North Am. 2008 Apr;22(2):305-18, vii. doi: 10.1016/j.hoc.2008.01.010.
7
Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study.接受自体造血细胞移植治疗的霍奇金淋巴瘤和非霍奇金淋巴瘤幸存者的远期效应：来自骨髓移植幸存者研究的报告
Biol Blood Marrow Transplant. 2007 Oct;13(10):1153-9. doi: 10.1016/j.bbmt.2007.06.003. Epub 2007 Jul 20.
8
Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study.异基因造血细胞移植后的晚期死亡率及长期存活者的功能状态：来自骨髓移植幸存者研究的报告
Blood. 2007 Nov 15;110(10):3784-92. doi: 10.1182/blood-2007-03-082933. Epub 2007 Aug 1.
9
Genotyping the risk of anthracycline-induced cardiotoxicity.对蒽环类药物引起心脏毒性的风险进行基因分型。
Cardiovasc Toxicol. 2007;7(2):129-34. doi: 10.1007/s12012-007-0024-2.
10
Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study.造血细胞移植幸存者中的糖尿病、高血压和心血管事件：来自骨髓移植幸存者研究的报告
Blood. 2007 Feb 15;109(4):1765-72. doi: 10.1182/blood-2006-05-022335. Epub 2006 Oct 17.
Zotero 插件